Schedule 13d

Filed by: HEALTHINVEST PARTNERS AB
Subject Company: BIO-IMAGING TECHNOLOGIES, INC.
Filed as of Date: 01/09/2009
View Original Filing on Edgar's
 
 
                                                                                
 
 
                                                                                      Exhibit 99.1
 

Joint Filing Agreement

The undersigned hereby agree that the Statement on Schedule 13D filed herewith (and any amendments thereto), relating to the common stock, $0.00025 par value, of Bio-Imaging Technologies, Inc., is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, on behalf of each such person.

January 9, 2009



 
HEALTHINVEST PARTNERS AB
   
 
By:  /s/ ANDERS HALLBERG
 
Name:  Anders Hallberg
 
Title:    Managing Director and CEO
   
   
 
HEALTHINVEST GLOBAL LONG/SHORT FUND
   
 
By:  /s/ ANDERS HALLBERG
 
Name:  Anders Hallberg
 
Title:    CEO of Managing Company
   
   
 
HEALTHINVEST VALUE FUND
   
 
By:  /s/ ANDERS HALLBERG
 
Name:  Anders Hallberg
 
Title:    CEO of Managing Company